Both NextGenVis and OptiVisT are dedicated vision science networks where PRC's pattern recognition expertise provides the applied industrial component.
PATTERN RECOGNITION COMPANY GMBH
German SME applying pattern recognition algorithms to visual function assessment, rehabilitation, and clinical vision science.
Their core work
Pattern Recognition Company GmbH (PRC) is a German technology SME based in Lübeck specialising in computational pattern recognition applied to visual function and perception. Their company name and consistent participation in Marie Skłodowska-Curie visual neuroscience training networks points to a core competence in software-based visual assessment — likely developing or applying algorithms that measure, analyse, or train visual capabilities in clinical or rehabilitation contexts. In MSCA-ITN consortia, private companies typically serve as industrial hosting sites for doctoral researchers, meaning PRC almost certainly provides real-world application environments where early-career scientists can validate translational tools. Their positioning at the intersection of computer vision technology and functional vision rehabilitation makes them a rare industrial bridge partner between academic neuroscience labs and clinical end-users.
What they specialise in
OptiVisT (2021–2025) explicitly targets functional vision and visual rehabilitation, suggesting PRC contributes tools or methods for supporting visually impaired users.
OptiVisT keywords include perception-action coupling, indicating PRC is moving toward systems that analyse how visual perception drives motor or behavioural responses.
OptiVisT is explicitly framed as a translational programme, and PRC's industrial role in the network positions them as the bridge from research findings to applied solutions.
How they've shifted over time
In their first project (NextGenVis, 2015–2019) PRC was embedded in a foundational visual neuroscience training network with no recorded applied keywords, suggesting their role was primarily as an industry host exposing PhD researchers to real-world pattern recognition environments. By their second project (OptiVisT, 2021–2025), the focus has sharpened considerably: keywords now centre on vision impairment, functional vision, visual rehabilitation, and perception-action coupling — all pointing toward clinical application rather than pure neuroscience. The trajectory is clear: PRC is moving from background industrial partner in basic science networks toward an active contributor to applied vision rehabilitation, where their pattern recognition software has direct therapeutic or assistive relevance.
PRC is evolving from a generic industrial host in academic training networks into a specialist contributor to applied visual rehabilitation — future collaborations are likely to involve assistive technology, low-vision support tools, or clinical diagnostic software built on their pattern recognition core.
How they like to work
PRC has exclusively taken the participant role across both H2020 projects, never leading a consortium — a pattern typical of SMEs that contribute specialised technology or industrial hosting capacity within researcher training networks rather than driving scientific agendas. Their 20 unique partners across just 2 projects indicates they have worked in mid-to-large consortia (roughly 10 partners per project), which is standard for MSCA-ITN networks. There is no evidence of repeated partners, suggesting they are comfortable integrating into new European research teams rather than relying on a fixed inner circle.
PRC has accumulated 20 unique consortium partners across 6 countries from only 2 projects, reflecting the broad pan-European composition typical of MSCA training networks. Their geographic footprint spans at least six EU member states, though no single country dominates as a repeat collaboration hub based on available data.
What sets them apart
PRC occupies an unusual niche: a private SME with a pattern recognition software identity operating inside academic neuroscience and clinical vision research consortia — a profile that is rare among German technology companies. Where most industrial MSCA partners are large medtech or pharma firms, PRC brings agile, specialised algorithmic capability that larger partners typically cannot offer at the same depth. For a consortium building a project around digital tools for visual assessment, low-vision assistive technology, or rehabilitation monitoring, PRC offers both technical expertise and the compliance track record of an experienced H2020 participant.
Highlights from their portfolio
- OptiVisTThe larger of PRC's two projects (EUR 252,788) and the one that crystallises their applied identity — a translational vision science programme explicitly targeting visual impairment and rehabilitation, with perception-action coupling as a keyword that signals sophisticated behavioural measurement capability.
- NextGenVisPRC's entry into H2020 as part of a pan-European visual neuroscience training network, establishing their credibility as an industrial partner in rigorous academic consortia and laying the foundation for the more applied OptiVisT participation that followed.